Abbott Laboratories Operating Margin 2006-2019 | ABT

Current and historical operating margin for Abbott Laboratories (ABT) over the last 10 years. The current operating profit margin for Abbott Laboratories as of September 30, 2019 is 18.21%.
Abbott Laboratories Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2019-09-30 $31.36B $4.31B 13.74%
2019-06-30 $30.94B $4.11B 13.27%
2019-03-31 $30.72B $3.78B 12.31%
2018-12-31 $30.58B $3.65B 11.94%
2018-09-30 $30.40B $3.14B 10.32%
2018-06-30 $29.58B $2.91B 9.84%
2018-03-31 $28.45B $2.41B 8.49%
2017-12-31 $27.39B $1.56B 5.71%
2017-09-30 $25.13B $1.70B 6.77%
2017-06-30 $23.61B $1.83B 7.75%
2017-03-31 $22.30B $2.26B 10.13%
2016-12-31 $20.85B $3.03B 14.51%
2016-09-30 $20.71B $3.05B 14.74%
2016-06-30 $20.56B $2.87B 13.95%
2016-03-31 $20.39B $2.78B 13.64%
2015-12-31 $20.41B $2.87B 14.05%
2015-09-30 $20.57B $2.88B 14.00%
2015-06-30 $20.50B $2.90B 14.13%
2015-03-31 $20.39B $2.84B 13.95%
2014-12-31 $20.25B $2.60B 12.84%
2014-09-30 $18.90B $2.19B 11.58%
2014-06-30 $18.65B $1.93B 10.37%
2014-03-31 $19.03B $1.88B 9.89%
2013-12-31 $19.66B $2.13B 10.85%
2013-09-30 $18.84B $1.69B 8.98%
2013-06-30 $19.28B $1.53B 7.93%
2013-03-31 $19.14B $1.47B 7.66%
2012-12-31 $19.05B $1.36B 7.14%
2012-09-30 $26.24B $3.47B 13.21%
2012-06-30 $30.79B $3.75B 12.18%
2012-03-31 $35.09B $4.96B 14.13%
2011-12-31 $38.85B $5.75B 14.80%
2011-09-30 $38.44B $5.50B 14.30%
2011-06-30 $37.30B $6.09B 16.31%
2011-03-31 $36.51B $5.92B 16.21%
2010-12-31 $35.17B $6.09B 17.31%
2010-09-30 $33.99B $6.12B 18.01%
2010-06-30 $33.08B $6.58B 19.89%
2010-03-31 $31.74B $6.65B 20.93%
2009-12-31 $30.76B $6.24B 20.27%
2009-09-30 $29.92B $6.12B 20.44%
2009-06-30 $29.66B $5.87B 19.80%
2009-03-31 $29.48B $5.61B 19.02%
2008-12-31 $29.53B $5.70B 19.29%
2008-09-30 $28.80B $5.47B 18.99%
2008-06-30 $27.68B $5.00B 18.06%
2008-03-31 $26.74B $4.78B 17.88%
2007-12-31 $25.92B $4.58B 17.67%
2007-09-30 $25.52B $2.83B 11.09%
2007-06-30 $24.71B $2.59B 10.48%
2007-03-31 $23.84B $1.95B 8.17%
2006-12-31 $22.48B $2.04B 9.09%
2006-09-30 $21.70B $3.58B 16.48%
2006-06-30 $21.51B $3.72B 17.28%
2006-03-31 $21.54B $4.27B 19.83%
2005-12-31 $22.34B $4.36B 19.53%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $158.560B $31.904B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $157.266B 21.73
Stryker (SYK) United States $82.983B 26.82
Boston Scientific (BSX) United States $58.973B 26.61
Baxter (BAX) United States $47.553B 28.84
EssilorLuxottica Societe Anonyme (ESLOY) France $33.044B 0.00
Zimmer Biomet Holdings (ZBH) United States $32.992B 20.38
Lonza Group Ag (LZAGY) Switzerland $31.551B 0.00
Coloplast (CLPBY) Denmark $29.743B 45.90
Terumo (TRUMY) Japan $27.160B 0.00
ResMed (RMD) United States $25.539B 44.37
Smith & Nephew SNATS (SNN) United Kingdom $20.941B 0.00
Sunny Optical Technology (SNPTF) China $18.537B 0.00
Insulet (PODD) United States $13.126B 624.47
Bio-Rad Laboratories (BIO) United States $12.082B 56.45
William Demant Holdings (WILYY) Denmark $7.896B 0.00
Perrigo (PRGO) Ireland $7.855B 14.65
Canopy Growth (CGC) Canada $7.731B 0.00
GN STORE NORD (GNNDY) Denmark $7.537B 0.00
Hill-Rom Holdings (HRC) United States $7.334B 21.09
DiaSorin S.p.A (DSRLF) Italy $7.161B 0.00
Haemonetics (HAE) United States $6.077B 37.41
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
Envista Holdings (NVST) United States $4.648B 0.00
ICU Medical (ICUI) United States $4.424B 28.84
NuVasive (NUVA) United States $4.127B 32.50
GW Pharmaceuticals (GWPH) United Kingdom $3.926B 0.00
Neogen (NEOG) United States $3.835B 63.83
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.773B 0.00
Quidel (QDEL) United States $3.367B 29.56
Agios Pharmaceuticals (AGIO) United States $3.033B 0.00
National Vision Holdings (EYE) United States $2.670B 60.27
Aurora Cannabis (ACB) Canada $1.847B 0.00
AtriCure (ATRC) United States $1.734B 0.00
TG Therapeutics (TGTX) United States $1.571B 0.00
Cardiovascular Systems (CSII) United States $1.560B 0.00
InMode (INMD) Israel $1.406B 0.00
NanoString Technologies (NSTG) United States $1.204B 0.00
Aphria (APHA) $1.151B 0.00
Phibro Animal Health (PAHC) United States $1.095B 21.65
VAREX IMAGING (VREX) United States $0.997B 20.71
PetIQ (PETQ) United States $0.956B 23.32
Quanterix (QTRX) United States $0.790B 0.00
Cerus (CERS) United States $0.779B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.721B 27.60
Lantheus Holdings (LNTH) United States $0.653B 16.31
Omeros (OMER) United States $0.653B 0.00
LeMaitre Vascular (LMAT) United States $0.602B 34.22
Surmodics (SRDX) United States $0.535B 61.52
MacroGenics (MGNX) United States $0.497B 0.00
Organigram Holdings (OGI) Canada $0.444B 0.00
HEXO (HEXO) $0.432B 0.00
OraSure Technologies (OSUR) United States $0.422B 25.33
Owens & Minor (OMI) United States $0.420B 15.56
Utah Medical Products (UTMD) United States $0.348B 24.71
Meridian Bioscience (VIVO) United States $0.338B 13.62
Zynex (ZYXI) United States $0.333B 37.63
BioLife Solutions (BLFS) United States $0.313B 127.42
Female Health (VERU) United States $0.275B 0.00
Bovie Medical (APYX) United States $0.268B 0.00
Repro-Med Systems (KRMD) United States $0.238B 0.00
Vapotherm (VAPO) United States $0.219B 0.00
Viemed Healthcare (VMD) United States $0.213B 22.48
United Health Products (UEEC) United States $0.188B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.178B 0.00
Liberty Health Sciences (LHSIF) Canada $0.171B 0.00
Cytosorbents (CTSO) United States $0.171B 0.00
Rockwell Medical (RMTI) United States $0.162B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.136B 0.00
Fonar (FONR) United States $0.131B 9.52
Chimerix (CMRX) United States $0.103B 0.00
Surface Oncology (SURF) United States $0.092B 0.00
MRI Interventions (CLPT) United States $0.089B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.086B 0.00
United-Guardian (UG) United States $0.079B 20.02
MTech Acquisition (KERN) United States $0.078B 0.00
Nephros (NEPH) United States $0.071B 0.00
Chembio Diagnostics (CEMI) United States $0.070B 0.00
FSD PHARMA INC (HUGE) Canada $0.044B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
NF Energy Saving (BIMI) China $0.033B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
GUARDION HEALTH (GHSI) United States $0.021B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.015B 0.00
Senestech (SNES) United States $0.006B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Valeritas Holdings (VLRX) United States $0.003B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00